| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $35,304,114 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R03CA289562 | Role of JMJD4 in Breast Cancer | 000 | 2 | NIH | 2/13/2025 | $72,500 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG3CA290310 | Discovery and Development of Natural Products for Interception of CRC | 001 | 2 | NIH | 5/22/2025 | $30,387 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG3CA290310 | Discovery and Development of Natural Products for Interception of CRC | 000 | 2 | NIH | 4/14/2025 | $273,488 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9449364 | Advanced Nursing Education Workforce | 00 | 3 | HRSA | 6/16/2025 | $649,393 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | 90DDUC0131 | Center for Learning and Leadership - University Center for Excellence in Developmental Disabilities | 01 | 4 | ACL | 6/23/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | 90DDUC0131 | Center for Learning and Leadership - University Center for Excellence in Developmental Disabilities | 00 | 4 | ACL | 6/13/2025 | $620,675 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY033841 | Thyroid Hormone Signaling and Cone Photoreceptor Degeneration | 000 | 4 | NIH | 4/10/2025 | $364,637 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI154274 | Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach | 000 | 5 | NIH | 4/11/2025 | $390,514 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T32GM154645 | Learning and Achievement in Biomedical Sciences | 000 | 1 | NIH | 6/23/2025 | $210,090 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R00GM141267 | Identification of novel osmosensing receptors in C. elegans | 000 | 4 | NIH | 1/21/2025 | $224,100 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG070915 | The role of IGF-1 signaling in vascular smooth muscle cells in age-related vascular cognitive impairment and dementia | 000 | 5 | NIH | 6/18/2025 | $349,958 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA273168 | Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold | 000 | 4 | NIH | 7/4/2025 | $580,663 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA053342 | Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms | 000 | 4 | NIH | 3/21/2025 | $525,353 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA053342 | Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms | 001 | 4 | NIH | 4/11/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01DA055073 | Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach | 000 | 3 | NIH | 1/9/2025 | $198,612 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AT012165 | The Oklahoma Study of Native American Pain Risk: Stress and Resilience Mechanisms | 000 | 4 | NIH | 4/25/2025 | $463,325 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01DA060986 | Postpartum Recovery from Opioid Use Disorder through Daily Acceptance and Commitment Therapy (PROUD2ACT) | 001 | 1 | NIH | 7/7/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01DA060986 | Postpartum Recovery from Opioid Use Disorder through Daily Acceptance and Commitment Therapy (PROUD2ACT) | 000 | 1 | NIH | 5/21/2025 | $174,378 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA060878 | Using Real Time Data to Examine the Impact of Product Characteristics on Young Adult ENDS Use | 000 | 1 | NIH | 4/23/2025 | $602,496 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA060878 | Using Real Time Data to Examine the Impact of Product Characteristics on Young Adult ENDS Use | 001 | 1 | NIH | 5/7/2025 | -$7,096 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA251451 | Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults | 001 | 5 | NIH | 5/30/2025 | $60,806 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA251451 | Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults | 000 | 5 | NIH | 4/9/2025 | $547,259 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG059718 | The role of hepatocyte necroptosis and inflammation in liver-brain crosstalk in aging | 002 | 7 | NIH | 7/10/2025 | $404,946 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA253391 | Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system | 000 | 5 | NIH | 1/8/2025 | $330,560 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA253391 | Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system | 001 | 5 | NIH | 6/17/2025 | $36,729 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY028608 | Caveolae-Based Mechanosensors for Conventional Outflow Regulation | 000 | 6 | NIH | 3/13/2025 | $604,777 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY030766 | Anti-ceramide immunotherapy for diabetic retinopathy | 001 | 5 | NIH | 4/4/2025 | $422,886 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK117965 | Regulation of Bile Acid Metabolism and Signaling in Metabolic Diseases | 001 | 6 | NIH | 7/1/2025 | $567,407 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01GM146956 | Regulation of OATP1B1 and OATP1B3 by lysine acetylation and lysine deacetylase inhibitors | 000 | 4 | NIH | 6/25/2025 | $290,000 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31HL176095 | Impacts of Phosphofructokinase-2 on Cardiac Electrophysiology and Function in Diabetes | 000 | 1 | NIH | 6/16/2025 | $38,024 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK134316 | Novel Roles of Cullin-RING E3 Ligases in Liver Pathophysiology | 000 | 3 | NIH | 2/17/2025 | $353,583 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK129656 | Understanding the metabolic pathology of pediatric obesity and NAFLD | 000 | 4 | NIH | 3/5/2025 | $503,196 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AG093578 | Cell-type specific role of melanocortin 4 receptor in inflammation and cognition with aging | 000 | 1 | NIH | 5/16/2025 | $393,250 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK133207 | ROCK, tight junctions and prematurity in the pathogenesis of necrotizing enterocolitis and neonatal sepsis. | 000 | 3 | NIH | 2/17/2025 | $434,040 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | D8854923 | Postdoctoral Training in General, Pediatric and Public Health Dentistry and Dental Hygiene | 00 | 1 | HRSA | 6/23/2025 | $440,530 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U01DK135007 | Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM) | 000 | 3 | NIH | 2/14/2025 | $569,717 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R03DE035156 | A Preliminary Elucidation of the Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer | 000 | 1 | NIH | 7/3/2025 | $286,000 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG085398 | Metabolic determinants of reactive astrogliosis and cognitive heterogeneity in aging | 000 | 2 | NIH | 5/2/2025 | $398,771 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG085398 | Metabolic determinants of reactive astrogliosis and cognitive heterogeneity in aging | 001 | 2 | NIH | 6/10/2025 | $35,447 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY035855 | Extracellular microRNA-mediated intercellular communication between retinal microglia and RPE | 000 | 2 | NIH | 5/29/2025 | $425,794 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA260449 | Exploiting gold nanoparticle as a probe to identify therapeutic targets | 001 | 4 | NIH | 6/9/2025 | $35,496 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA260449 | Exploiting gold nanoparticle as a probe to identify therapeutic targets | 000 | 4 | NIH | 11/20/2024 | $319,463 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA233193 | A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials | 001 | 6 | NIH | 3/7/2025 | $1,163,038 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA255840 | Chemotherapy-induced vascular cognitive impairment: role of endothelial senescence | 001 | 5 | NIH | 6/2/2025 | $33,169 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA255840 | Chemotherapy-induced vascular cognitive impairment: role of endothelial senescence | 000 | 5 | NIH | 12/17/2024 | $298,519 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA287044 | Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub | 002 | 2 | NIH | 5/29/2025 | $82,101 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA287044 | Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub | 001 | 2 | NIH | 4/14/2025 | $450,450 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA287044 | Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub | 000 | 2 | NIH | 12/5/2024 | $738,924 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK131064 | Sulfur Amino Acid Metabolism and Regulation of Hepatic Metabolic Flexibility | 001 | 4 | NIH | 6/18/2025 | $41,212 |
|
